Bipartisan E&C Committee Leaders Request Info on Lagging Approvals for Complex Generic Drugs
01.17.2020
WASHINGTON, DC – Bipartisan Energy and Commerce leaders sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn, M.D. to request information on the FDA's process for approving complex generic drugs.
The letter was sent by Energy and Commerce Republican Leader Greg Walden (R-OR), Chairman Frank Pallone, Jr. (D-NJ), Health Subcommittee Republican Leader Michael Burgess M.D. (R-TX), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Oversight and Investigations Subcommittee Chair Diana DeGette (D-CO).
"We are interested in identifying ways...
Letter to FDA on Lagging Approvals for Complex Generic Drugs
01.17.2020
Excerpt: "We are interested in identifying ways to help reduce the costs of health care for patients, including the costs of prescription drugs. Generic versions of brand-name drugs provide substantial cost savings for patients and third-party payers and account for nine out of ten prescriptions filled in the U.S.," the bipartisan Committee members wrote to FDA.
CLICK HERE to read the letter to FDA.
Bipartisan E&C Committee Leaders Request GAO Review of Indian Health Service Infrastructure
01.17.2020
WASHINGTON, DC – Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ), Republican Leader Greg Walden (R-OR), Rep. Raul Ruiz, M.D. (D-CA) and Rep. Markwayne Mullin (R-OK) sent a letter to the U.S. Government Accountability Office (GAO) today requesting a review of the impact the Indian Health Service’s (IHS) aging infrastructure has on patient access to quality health care and positive health outcomes.
The IHS is responsible for providing health care to approximately 2.56 million American Indian and Alaska Native people located across the country at 170 IHS and tribally run...